Literature DB >> 15256278

Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant.

Frank M Dautzenberg1, Jacqueline Higelin, Sandra Wille, Olaf Brauns.   

Abstract

The mouse corticotropin-releasing factor (CRF) type 2a receptor (CRF2(a)) splice variant was cloned by a PCR-based approach. The corresponding cDNA was found to encode a 411-amino acid polypeptide with highest sequence homology to the rat CRF2(a) receptor. By semiquantitative reverse transcriptase PCR (RT-PCR) analysis, the CRF2(b) mRNA was mainly found in the heart and skeletal muscle with only low level expression in the brain. In contrast, CRF2(a) mRNA was restricted to the brain with major expression sites in the cortex, hippocampus, hypothalamus and telencephalon. Binding and cyclic AMP stimulation studies showed a similar ligand selective profile for both mCRF2 receptor splice variants. A notable exception however, was urotensin I which displayed a approximately 3-fold higher affinity for the CRF2(a) receptor and also stimulated cyclic AMP production in mCRF2(a)-transfected cells with a approximately 3-fold higher potency than in mCRF2(b)-transfected cells. These data show that the mouse like other mammalian species expresses two ligand-selective CRF2 receptor splice variants and that the mCRF2(a) receptor is the predominant central CRF2 receptor in the mouse. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256278     DOI: 10.1016/j.regpep.2004.04.009

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  10 in total

Review 1.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

Review 2.  Corticotropin-releasing factor signaling and visceral response to stress.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Exp Biol Med (Maywood)       Date:  2010-10

Review 3.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

4.  Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect.

Authors:  Pu-Qing Yuan; S Vincent Wu; Charalabos Pothoulakis; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

5.  Expression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors.

Authors:  Eric Gutknecht; Richard L Hauger; Ilse Van der Linden; Georges Vauquelin; Frank M Dautzenberg
Journal:  J Neurochem       Date:  2007-11-01       Impact factor: 5.372

6.  Soluble corticotropin-releasing hormone receptor 2alpha splice variant is efficiently translated but not trafficked for secretion.

Authors:  Ryan T Evans; Audrey F Seasholtz
Journal:  Endocrinology       Date:  2009-06-11       Impact factor: 4.736

7.  Corticotrophin-releasing factor, related peptides, and receptors in the normal and inflamed gastrointestinal tract.

Authors:  Roeland Buckinx; Dirk Adriaensen; Luc Van Nassauw; Jean-Pierre Timmermans
Journal:  Front Neurosci       Date:  2011-04-20       Impact factor: 4.677

8.  Brain-Gut Interactions in IBS.

Authors:  Jakub Fichna; Martin A Storr
Journal:  Front Pharmacol       Date:  2012-07-05       Impact factor: 5.810

Review 9.  CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Neurosci       Date:  2014-03-18       Impact factor: 4.677

Review 10.  Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure.

Authors:  Lizhen Chen; Dayun Yu; Shuang Ling; Jin-Wen Xu
Journal:  Front Cardiovasc Med       Date:  2022-09-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.